Azimuth Capital Investment Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.78M Buy
108,384
+57,148
+112% +$4.4M 0.29% 115
2025
Q4
$4.07M Buy
51,236
+48,443
+1,734% +$3.82M 0.15% 160
2025
Q3
$211K Buy
+2,793
New +$191K 0.01% 290
2024
Q2
Sell
-2,970
Closed -$237K 308
2024
Q1
$237K Buy
2,970
+220
+8% +$16.8K 0.01% 289
2023
Q4
$217K Sell
2,750
-593
-18% -$42.2K 0.01% 293
2023
Q3
$233K Sell
3,343
-104,831
-97% -$7.43M 0.01% 280
2023
Q2
$7.48M Sell
108,174
-72,992
-40% -$5.19M 0.36% 105
2023
Q1
$13.5M Sell
181,166
-55,080
-23% -$4.62M 0.66% 52
2022
Q4
$22M Sell
236,246
-74,921
-24% -$7.23M 1.12% 18
2022
Q3
$29.7M Buy
311,167
+62,965
+25% +$6.23M 1.62% 4
2022
Q2
$23M Buy
+248,202
New +$24.2M 1.16% 15

Other funds holding CVS

Azimuth Capital Investment Management's CVS Position: Q1 2026 in Review

Azimuth Capital Investment Management increased its CVS Health (CVS) stake by 112% in Q1 2026, buying an estimated $4.4M and bringing the position to 108,384 shares worth $7.78M. The position accounts for 0.29% of the portfolio, ranked #115.

Azimuth Capital Investment Management first reported a position in CVS in Q2 2022 and has held it in 11 quarters since. The position peaked at $29.7M in Q3 2022. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Azimuth Capital Investment Management held 108,384 shares of CVS Health worth $7.78M as of Q1 2026.
  • Azimuth Capital Investment Management bought 57,148 CVS Health shares in Q1 2026, an estimated $4.4M.
  • CVS Health made up 0.29% of Azimuth Capital Investment Management's portfolio in Q1 2026, its #115 holding.
  • Azimuth Capital Investment Management first reported a position in CVS Health in Q2 2022 and has held it in 11 quarters since.
  • Azimuth Capital Investment Management's CVS Health position peaked at $29.7M in Q3 2022.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q1 2026, filed 12 May 2026.